Transforming growth factor-β1 increases CXCR4 expression, stromal-derived factor-1α-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages

被引:56
作者
Chen, S
Tuttle, DL
Oshier, JT
Knot, HJ
Streit, WJ
Goodenow, MM
Harrison, JK
机构
[1] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA
关键词
HIV-1; CXCR4; CCR5; macrophages; microglia;
D O I
10.1111/j.1365-2567.2004.02110.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stromal-derived factor-1 (SDF-1/CXCL12) and its receptor CXCR4 play crucial roles in leukocyte migration and activation, as well as embryogenesis, angiogenesis, cancer and viral pathogenesis. CXCR4 is one of the major human immunodeficiency virus-1 (HIV-1) coreceptors on macrophages. In many tissues macrophages are one of the predominant cell types infected by HIV-1 and act as a reservoir for persistent infection and viral dissemination. In patients infected by HIV-1, blood and tissue levels of transforming growth factor-beta 1 (TGF-beta 1) are increased. The purpose of this study was to evaluate the effects of TGF-beta 1 on CXCR4 expression and function in primary human monocyte-derived macrophages (MDMs) and rat microglia. TGF-beta 1 up-regulated CXCR4 and enhanced SDF-1 alpha-stimulated ERK1,2 phosphorylation in these cells. The increased CXCR4 expression in human MDMs resulted in increased susceptibility of the cells to entry by dual-tropic CXCR4-using HIV-1 (D-X4). In contrast, TGF-beta 1 failed to increase CCR5 expression or infection by a CCR5-using virus in MDMs. Our data demonstrate that TGF-beta 1 enhances macrophage responsiveness to SDF-1 alpha stimulation and susceptibility to HIV-1 by selectively increasing expression of CXCR4. The results suggest that increased expression of CXCR4 on macrophages may contribute to the emergence of dual-tropic X4 viral variants at later stages of HIV-1 infection.
引用
收藏
页码:565 / 574
页数:10
相关论文
共 58 条
  • [1] Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates
    Albright, AV
    Shieh, JTC
    Itoh, T
    Lee, B
    Pleasure, D
    O'Connor, MJ
    Doms, RW
    González-Scarano, F
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (01) : 205 - 213
  • [2] Stromal cell-derived factor-1α induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway
    Bajetto, A
    Barbero, S
    Bonavia, R
    Piccioli, P
    Pirani, P
    Florio, T
    Schettini, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 77 (05) : 1226 - 1236
  • [3] The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
    Bleul, CC
    Farzan, M
    Choe, H
    Parolin, C
    ClarkLewis, I
    Sodroski, J
    Springer, TA
    [J]. NATURE, 1996, 382 (6594) : 829 - 833
  • [4] Transforming growth factor-β induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein
    Brown, KA
    Roberts, RL
    Arteaga, CL
    Law, BK
    [J]. BREAST CANCER RESEARCH, 2004, 6 (02) : R130 - R139
  • [5] TGF-β1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia
    Chen, SZ
    Luo, DF
    Streit, WJ
    Harrison, JK
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2002, 133 (1-2) : 46 - 55
  • [6] GENOMIC SEQUENCING
    CHURCH, GM
    GILBERT, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07): : 1991 - 1995
  • [7] INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS
    CONNOR, RI
    MOHRI, H
    CAO, YZ
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (04) : 1772 - 1777
  • [8] Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection
    Crowe, SM
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (06): : 777 - 783
  • [9] Franitza S, 2002, EUR J IMMUNOL, V32, P193, DOI 10.1002/1521-4141(200201)32:1<193::AID-IMMU193>3.0.CO
  • [10] 2-H